Stock listing
LFMD Stock Price, News, Filings & Events — Lifemd, Inc.
Selected listing: LFMD · NASDAQ · USD · US
This page tracks Lifemd, Inc.'s LFMD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LFMD:NASDAQ. LFMD:NASDAQ is the stock-level entry point for investors researching Lifemd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lifemd, Inc. is a public company traded under the ticker LFMD in the American market. With a market capitalization of approximately $179.4 million, Lifemd focuses on innovative healthcare solutions. The company aims to enhance patient outcomes through its advanced medical technologies and services.
- Ticker
- LFMD:NASDAQ
- Asset type
- Stock
- Market cap
- $151.4M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD
Lifemd, Inc. LFMD:NASDAQ stock context
This page tracks Lifemd, Inc.'s LFMD:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LFMD:NASDAQ. LFMD:NASDAQ is the stock-level entry point for investors researching Lifemd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lifemd, Inc. is a public company traded under the ticker LFMD in the American market. With a market capitalization of approximately $179.4 million, Lifemd focuses on innovative healthcare solutions. The company aims to enhance patient outcomes through its advanced medical technologies and services.
Latest news from Lifemd, Inc.
UPDATE - LifeMD Reports Second Quarter 2026 Results
August 5, 2026
LifeMD Reports Second Quarter 2026 Results
August 5, 2026
LifeMD to Report Second Quarter 2026 Financial Results on August 5
July 24, 2026
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
June 22, 2026
LifeMD Appoints Umesh Sripad as Chief Technology Officer
June 1, 2026
Lifemd, Inc. earnings calls
LifeMD, Inc. (LFMD) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call
March 9, 2026 · Replay with transcript and chapters
LifeMD, Inc. (LFMD) Q3 2025 Earnings Call
November 17, 2025 · Replay with transcript and chapters
LifeMD, Inc. (LFMD) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
LifeMD, Inc. (LFMD) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Lifemd, Inc.
Lifemd, Inc. investor report
Review AI stock analysis and investor report context for LFMD:NASDAQ.
Lifemd, Inc. company profile
View the public company page for Lifemd, Inc. on 6ix.
Lifemd, Inc. news
Read company news and market updates connected to Lifemd, Inc..
Lifemd, Inc. investor events
Find investor webinars, events, and replay context for Lifemd, Inc..
Alternate listings
LFMDP:NASDAQ
US · USD
Alternate listing for Lifemd, Inc.; the primary context on this page is LFMD:NASDAQ.
LFMD:BOATS
US · USD
Alternate listing for Lifemd, Inc.; the primary context on this page is LFMD:NASDAQ.
LFMDP:BOATS
US · USD
Alternate listing for Lifemd, Inc.; the primary context on this page is LFMD:NASDAQ.